Get started
Author

Katsuya Makihara

Observed name: KATSUYA MAKIHARA
ORCID: 0000-0003-4153-8555
Observed ORCID: 0000-0003-4153-8555
OpenAlex ID: A5073073859
A pilot study of pharmacokinetically guided dose management of capecitabine in CRC patients.
2012 · Katsuya Makihara, Hideyuki Mishima, et al. · Journal of Clinical Oncology · 10
Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study
2023 · Satoshi Dote, Eiji Shiwaku, et al. · International Journal of Clinical Oncology · 9
PDF
Decreased percentage of neutrophil is a predict factor for the efficacy of trifluridine and tipiracil hydrochloride for pretreated metastatic colorectal cancer
2019 · Katsuya Makihara, Rino Fukui, et al. · Journal of Gastrointestinal Oncology · 9
PDF
Effectiveness of Interventions by Pharmacists in Ensuring Safety and Efficacy of Outpatient Chemotherapy Prescriptions
2010 · Katsuya Makihara, Miki Ohta, et al. · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · 9
PDF
Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients
2017 · Katsuya Makihara, Sayaka Nakamura, et al. · Cancer Chemotherapy and Pharmacology · 6
Influence of Concomitant Polypharmacy on Docetaxel-induced Febrile Neutropenia
2021 · KATSUYA MAKIHARA, YUKA SHIMEDA, et al. · Cancer Diagnosis & Prognosis · 5
Plasma concentrations of 5-FU and creatinine clearance as predictive markers for severe toxicities of capecitabine in patients with colorectal cancer.
2013 · Katsuya Makihara, Hideyuki Mishima, et al. · Journal of Clinical Oncology · 4
Optimal follow-up duration of cardiac function tests in patients treated with trastuzumab: an analysis using the Japanese Adverse Drug Event Report (JADER) database
2025 · Katsuya Makihara, Keisuke Kongo, et al. · International Journal of Clinical Oncology · 3
Personalized dose monitoring of fluorouracil and metabolites of capecitabine (XELODA) in colorectal cancer patients (PersonaX).
2016 · Masato Nakamura, Katsuya Makihara, et al. · Journal of Clinical Oncology · 2
Pre-treatment serum total bilirubin level as an indicator of optimal CPT-11 dosage
2014 · Katsuya Makihara, Sayaka Azuma, et al. · Cancer Chemotherapy and Pharmacology · 2
[Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer].
2014 · Akiko Enami, Norikazu Masuda, et al. · PubMed · 2
[Effect of oral dexamethasone given 24 hours previously on docetaxel-induced edema: a retrospective study].
2014 · Ai Kato, Norikazu Masuda, et al. · PubMed · 2
Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study
2026 · Tatsuya Ohtsubo, Kazuhiro Yamamoto, et al. · Journal of Pharmaceutical Health Care and Sciences · 1
Administration of Immune Checkpoint Inhibitors to Patients on Warfarin May Elevate PT-INR
2024 · Kazuya Uenoyama, Masahide Onoue, et al. · YAKUGAKU ZASSHI · 1
PDF
Medical Economic Effect of Pharmaceutical Interventions by Board-Certified Pharmacists in Palliative Pharmacy for Patients with Cancer Using Medical Narcotics in Japan: A Multicenter, Retrospective Study
2024 · Takehiro Kawashiri, Hideki Sugawara, et al. · Journal of Nippon Medical School · 1
PDF
A Multicenter Retrospective Observational Study Analyzing the Effect of Polypharmacy on Oxycodone Tolerability
2024 · Katsuya Makihara, Yoshihiro Yamamoto, et al. · Journal of Pain & Palliative Care Pharmacotherapy · 1
Effect of renal function on continuation of S-1 adjuvant chemotherapy in gastric cancer patients.
2015 · Katsuya Makihara, Sayaka Azuma, et al. · Journal of Clinical Oncology · 1
Association between prophylactic desloratadine use and docetaxel-induced skin toxicities in patients with early-stage breast cancer: an inverse probability-weighted retrospective cohort study
2026 · Katsuya Makihara, Keisuke Kongo, et al. · Supportive Care in Cancer
Risk Factors for Peripheral Intravenous Infusion–Related Local Adverse Events Associated With Fosaprepitant: A Retrospective Study
2026 · Kayo Motomura, Keisuke Kongo, et al. · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
PDF
Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study
2026 · Tatsuya Ohtsubo, Kazuhiro Yamamoto, et al. · Journal of Pharmaceutical Health Care and Sciences
PDF
The impact of low-volume hydration on kidney function in low-dose cisplatin therapy for biliary tract cancer: a multicentre retrospective cohort study
2026 · Hiroyuki Watanabe, Katsuya Makihara, et al. · Figshare
The impact of low-volume hydration on kidney function in low-dose cisplatin therapy for biliary tract cancer: a multicentre retrospective cohort study
2026 · Hiroyuki Watanabe, Katsuya Makihara, et al. · Journal of Chemotherapy
Additional file 1 of Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study
2026 · Tatsuya Ohtsubo, Kazuhiro Yamamoto, et al. · Figshare
Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study
2026 · Tatsuya Ohtsubo, Kazuhiro Yamamoto, et al. · Figshare
Effect of renal function on continuation of S-1 adjuvant chemotherapy in gastric cancer patients
2015 · Katsuya Makihara, Azuma Sayaka, et al. · Annals of Oncology
PDF
Works count: 27
Citation count: 68
H-index: 5
I10-index: 1
Year
Topic
Type